Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery.
Candida albicans endocarditis involves infrequently the tricuspid valve and involvement of the pulmonic valve is rare. We report our experience with an immunosuppressed liver-transplanted female who developed both tricuspid and pulmonic valve endocarditis, review the literature and discuss the importance of effective antimycotic therapy combined with surgical replacement of the affected valve.
Salamon
Suheil Andreas
SA
Department of Clinical Microbiology, Arhus University Hospital, Arhus, Denmark. suansa@vgs.vejleamt.dk
Fuursted
Kurt
K
Egeblad
Henrik
H
Petersen
Eskild
E
Ott
Peter
P
D000328:Adult; D002176:Candida albicans / Q000302:isolation & purification*; D002177:Candidiasis / Q000175:diagnosis* / Q000628:therapy; D004696:Endocarditis / Q000276:immunology / Q000382:microbiology* / Q000628:therapy; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006349:Heart Valve Diseases / Q000276:immunology / Q000382:microbiology* / Q000628:therapy; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D011664:Pulmonary Valve / Q000382:microbiology* / Q000601:surgery; D014261:Tricuspid Valve / Q000382:microbiology* / Q000601:surgery
D015725:Fluconazole